17 articles for JA McCammon
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Exploring the influence of the protein environment on metal-binding pharmacophores.

University of California
Active site binding modes of HIV-1 integrase inhibitors.

University of California
Developing a dynamic pharmacophore model for HIV-1 integrase.

University of California
Theoretical study of inhibition of adenosine deaminase by (8R)-coformycin and (8R)-deoxycoformycin.

University of California
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.

University of California San Diego
Computer-aided identification of Trypanosoma brucei uridine diphosphate galactose 4'-epimerase inhibitors: toward the development of novel therapies for African sleeping sickness.

University of California San Diego
A computational model of binding thermodynamics: the design of cyclin-dependent kinase 2 inhibitors.

University of California
The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L.

University of California
Identification of triazinoindol-benzimidazolones as nanomolar inhibitors of the Mycobacterium tuberculosis enzyme TDP-6-deoxy-d-xylo-4-hexopyranosid-4-ulose 3,5-epimerase (RmlC).

University of Pennsylvania
Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase.

University of California
Computational analysis of PKA-balanol interactions.

University of California At San Diego
N2-(3,4-dimethylphenyl)-6-((4-(p-tolyl)piperazin-1-yl)methyl)-1,3,5-triazine-2,4-diamine

Glucox Biotech
Pharmaceutical compositions comprising RET inhibitors and methods for the treatment of cancer

Queen'S University At Kingston
Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.

Mcgill University
Structure-activity relationship studies of 5-benzylaminoimidazo[1,2-c]pyrimidine-8-carboxamide derivatives as potent, highly selective ZAP-70 kinase inhibitors.

Kissei Pharmaceutical